For further information, please contact: Jonas Wiström, President and CEO +46 70 608 12 20 Stefan Johansson, CFO +46 70 224 24 01 Viktor Svensson, Director Corporate Information +46 70 657 20 26 First quarter 2014 * Net sales amounted to SEK 2,276 million (2,125) * Operating profit totalled SEK 200 million (166) * Operating margin was 8.8 percent (7.8) * Operating profit, excluding non-recurring items, totalled SEK 200 million (183) * Operating margin, excluding non-recurring items, was 8.8 percent (8.6) * Profit after tax totalled SEK 149 million (121) * Earnings per share, before dilution: SEK 3.83 (3.04) A few words from the President, Jonas Wiström: ÅF's operating profit rose to SEK 200 million (166) in the first quarter 2014. This is the highest first-quarter result ÅF has reported to date, even taking into account the fact that last year's first quarter was affected negatively by SEK 17 million in restructuring costs. The operating margin climbed to 8.8 percent (7.8) in the quarter. The improved profit is chiefly attributable to slightly higher capacity utilisation and synergies from completed acquisitions. Growth for the ÅF Group amounted to 7 percent in the first quarter, of which 3 percent was organic. Adjusted for ÅF Russia, which saw sales volumes continue to diminish, ÅF grew by just over 12 percent in the first quarter, of which 8 percent was organic. ÅF now has a workforce of over 7,000 highly qualified employees, with a stronger and more comprehensive range of engineering services to offer our customers than ever before. On top of that, ÅF offers access to around 20,000 engineers as part of a unique network. With the exception of Russia and Spain, ÅF's market continued to experience a gradual improvement during the first quarter. The highest levels of profit were delivered by the Infrastructure and Industry divisions, with operating margins of 11.9 (13.9) and 10.1 (8.0) percent respectively. Industry stood out for its ability to combine rising profit with growth of over 20 percent in Q1. The Technology Division delivered a stable margin of 8.6 (8.6) percent, which was nevertheless an increase compared to the fourth quarter last year. International's margin climbed to 4.0 percent (2.4). However, growth in the International Division was negative due to persistently weak levels of demand in Russia and Spain. Market prospects for the rest of 2014 remain cautiously optimistic. The market for infrastructure is deemed to be persistently strong, while the market outlook for Industry is a positive improvement on a year ago. The energy market continues to be characterised by low levels of investment in Europe, with a more encouraging outlook for the markets in Asia and South America. Interest in ÅF as an employer remains very strong. At the beginning of April, ÅF was on Randstad Award's list of Sweden's 20 most attractive employers - all industry categories. The Randstad Award is the world's largest independent employer branding survey. For ÅF, as a knowledge-intensive company, being able to recruit the top engineers is a key success factor. In order to further consolidate ÅF's position as an attractive employer we are launching a strategic investment and process, Even Odds, to continue to increase the proportion of female managers and employees in the company. ÅF's ultimate goal is to be the most profitable company among its closest comparable competitors in the industry and achieve an operating margin of at least 10 percent over a business cycle. This shall be combined with growth - both organic and through corporate acquisitions. At the end of the first quarter, at ÅF's Capital Markets Day, the company presented new longterm goals including sales of at least EUR 2 billion by the year 2020. Group Head Office: ÅF AB (publ), SE-169 99 Stockholm, Sweden Visitors' address: Frösundaleden 2, 169 70 Solna, Sweden Tel. +46 10 505 00 00 Fax +46 10 505 00 10 www.afconsult.com / info@afconsult.com Corporate ID number 556120-6474 This report has not been subject to review by the company's auditors. The information in this interim report fulfils ÅF AB's disclosure requirements under the provisions of the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was released for publication at 11.00 a.m. on 5 May, 2014. All assumptions about the future that are made in this report are based on the best information available to the company at the time the report was written. As is the case with all assessments of the future, such assumptions are subject to risks and uncertainties, which may mean that the actual outcome differs from the anticipated result. This is a translation of the Swedish original. The Swedish text is the binding version and shall prevail in the event of any discrepancies. The full report including tables (pdf) is available for download [HUG#1782493]
ÅF AB Interim report January - March 2014 For further
Top 10 Most Recent News Articles
Poland's Economic Boom: A Case for Freedom and Growth
Poland's Remarkable Journey to Economic Power Freedom, they say, fuels progress—and Poland stands as a pulsating testament to that very idea. Thirty-odd years ago, shedding the chains of Soviet-imposed communism, Poland was all systems go, taking the wheel of its own destiny. For the first time, Polish innovation and industry were unleashed, paving the road toward...
Continue Reading
Bramshill Fund Takes Top Spot in 2026 Fund Awards
Another Feather in Bramshill's Cap They've done it again, folks. The Bramshill Multi-Strategy Income Fund has just snagged the 40 Act Fund of the Year award at the 2026 Hedge Fund Performance Awards. This ain't just another plaque for the wall; it's a nod to some serious heavy lifting by the folks handling this beast of a portfolio. The award, dished out by With...
Continue Reading
Sino Biological Boosts AI Protein Discovery Efficiency
Dissecting the Bridge Between AI and Biology In the cutthroat world of biotech, every second counts. Sino Biological is taking a good hard look at bridging AI and practical applications with their shiny new 4RISE™ solution. The stakes couldn't be higher—turning computer-generated protein ideas into lab-tested realities is no small feat. And believe me, researchers...
Continue Reading
Full Sail's Reach Expands with Film School Honor
Full Sail's Cinematic Spotlight Moment Alright, folks, you're hearing it right: Full Sail University's caught the spotlight in TheWrap Magazine's annual who's-who of film schools for 2026. That's a pat on the back any educational institution would kill for, highlighting that Full Sail is playing with the big boys when it comes to film education. Beyond Classic Classroom...
Continue Reading
Alyssa Bunch: Big Moves in Tennessee Real Estate
Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...
Continue Reading
RLX Technology Gears Up for Q3 Earnings Call Ahead
Under the Microscope: RLX Q3 2026 Earnings Get ready, because November 20 is shaping up to be a real event for RLX Technology watchers. The e-vapor heavyweight is gonna drop its Q3 results right before the crack of dawn U.S. markets open. Now, that's a time that stirs more coffee pots than debates—at 7:00 AM Eastern Time, to be precise. So, you better be braced for some...
Continue Reading
GCC's Path to 10 Gbps: U6GHz Revolution Unfolds
On the Journey to 10 Giga: The U6GHz Leap You know, sometimes the telco world kicks up a fuss about speed, and this time, it’s the upper 6 GHz (or U6GHz) band that’s got everyone abuzz. At the Telecom Review Leaders' Summit in Dubai, industry bigwigs gathered to discuss how this spectrum could catapult the GCC into the 10 Gbps connectivity stratosphere. Fancy-talk...
Continue Reading
DentScribe Smashes AI Perio Chart Test with Perfect Score
High Stakes in Dental Tech: DentScribe's Impeccable Show The dental tech world just got a jolt, and it's not from your morning coffee. DentScribe, the brains cooking up some AI magic in Sunnyvale, has unleashed a real heavyweight. They dropped the mic on their Periodontal Charting Benchmark 1.0 by acing 68 out of 68 tests without breaking a sweat—literal perfection in...
Continue Reading
Suiteify Teams Up With Findity for German Launch
Striking a Partnership That Makes Sense Today's deal rolls in like thunder on a quiet afternoon. Suiteify, the master of HR and business software in the DACH region, hooks up with Findity to unleash a new game-changer in Germany. They’re cooking up Suiteify Expense & Travel, and if you're in the mid-sized business space, it’s worth a pause to see how these two horses...
Continue Reading
2026 Chinese Congress to Advance Integrative Oncology
Changsha Set to Host a Global Convergence in Oncology For those interested in the blend of age-old wisdom and cutting-edge science, it’s time to tune into what’s happening in Changsha, China. The 2026 Chinese Congress on Holistic Integrative Oncology is about to kick off from November 12 to 15, and it's got quite the lineup of star-studded brainpower in the oncology...
Continue ReadingTop 5 Most Recently Viewed Articles
Bon Secours Mercy Health Collaborates on New Cardiac Facility
A New Era in Cardiovascular Care In an exciting development for cardiovascular health services, Bon Secours Mercy Health, AlignedCardio, and Compass Surgical Partners have joined forces to establish a cutting-edge cardiovascular surgery center. This center, named the Short Pump Cardiovascular Ambulatory Surgery Center, is slated to open its doors in late 2025. The new...
Continue Reading
Fluence Energy Faces Investigation Over Securities Issues
Fluence Energy Under Scrutiny for Potential Securities Fraud Pomerantz LLP is proactively investigating claims on behalf of investors linked to Fluence Energy, Inc. (NASDAQ: FLNC). This investigation aims to determine whether Fluence, along with its officers and directors, have participated in any unlawful business practices or securities fraud that could affect its...
Continue Reading
Oramed Pharmaceuticals Enters $11.5 Million Clinical Trial Deal
Oramed Pharmaceuticals Inc. (NASDAQ: ORM) landed a key deal back in 2024 with InClin, Inc., a clinical research outfit that could shift the gears on their clinical trials. This agreement is meant to fuel Oramed's Phase 3 clinical trial efforts, as detailed in their filing. The stakes are high here; we’re talking about an oral insulin capsule aimed at type 2...
Continue Reading
Charles El-Moussa Joins MRED as General Counsel
Charles El-Moussa Joins MRED as General Counsel Midwest Real Estate Data (MRED) has officially announced that Charles El-Moussa is stepping in as the company’s new General Counsel, effective immediately. A Strategic Move for MRED El-Moussa's appointment is a significant and strategic step for MRED. He will play a crucial role in providing legal guidance as the company...
Continue Reading
Caristo Diagnostics Celebrates Recognition for Cardiac Technology
Caristo Diagnostics Triumphs in Digital Health Awards Caristo Diagnostics, a pioneering entity in the field of cardiovascular disease diagnostics and risk prediction, has recently celebrated a significant achievement. The company was awarded the prestigious Digital Health Hub Foundation's Digital Health Awards, where it was acknowledged as a 'Rising Star' in the Provider...
Continue Reading